Open original FDA record ↗Recall record
- FDA identifier
- Z-0426-2021
- Company in FDA record
- Epitope Diagnostics, Inc.
- FDA record creation date
- Nov 6, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value.
Source facts
- Action
- On 10/01/20, the firm, Epitope Diagnostics Inc. (EDI), sent "URGENT: EDI" Novel Coronavirus COVID-19 IgG ELISA Kit Recall" notices were sent to customers. Customers were asked to do the following: Results where the assay controls do not meet the manufacturer's defined specifications should be considered invalid and repeated with another lot. Immediately examine your inventory and quarantine product subject to recall. In addition, if you have further distributed this product, please identify your customers and notify them at once of this product recall. Complete and promptly return the Customer Response Form by Email to: cs@epitopediagnostics.com or Fax to: 858-693-7877. Your notification to your customers may be enhanced by including a copy of this recall notification letter. For customers located within United States, we will ask that you return this affected product to the recalling firm. For customers located outside United States, please destroy the affected product. For any questions, please refer to EDIs Quality Assurance and Regulatory Affairs Manager, Stefanie Dallezotte, by email: lenart@epitopediagnostics.com or by telephone: +1 858 693 7877.
- Initiated
- 2020-10-01
- Root cause
- Nonconforming Material/Component
- Distribution
- U.S Distribution.: NH, CO, OR, CA, FL, NY, MD, NJ, IL, NC, MI, TX, PA, MA, OH, NM, VA, SC, HI, and TN.
- Recall number
- Z-0426-2021
- Recall status
- Open, Classified
- CDRH record ID
- 183989
- FDA record created
- 2020-11-06
- Recall event number
- 86516